Renaissance Capital logo

IMGO News

US IPO Weekly Recap: The summer IPO market heats up in a 13 IPO week

STVN

After a slow start to the month, the IPO market revved back to life with 13 IPOs coming to market this past week. SPAC activity picked up, with seven blank check IPOs raising $940 million. New filers continued to flood the IPO pipeline, with fourteen IPOs and...read more

Imago BioSciences prices upsized IPO at $16 high end, targeting bone marrow diseases

Imago BioSciences logo

Imago BioSciences, a Phase 2 biotech developing small molecules for bone marrow cancer and diseases, raised $134 million by offering 8.4 million shares at $16, the high end of the range of $14 to $16. The company plans to raise an additional $20 million in...read more

Bone marrow disease biotech Imago BioSciences sets terms for $105 million IPO

Imago BioSciences logo

Imago BioSciences, a Phase 2 biotech developing small molecules for bone marrow cancer and diseases, announced terms for its IPO on Monday. The South San Francisco, CA-based company plans to raise $105 million by offering 7 million shares at a price range of...read more

US IPO Week Ahead: Real estate, post-pandemic plays and more in a 15 IPO week

STVN

Updated Monday, 7/12. After a slow holiday week, 15 IPOs are scheduled to raise nearly $4 billion in the week ahead. A handful of SPACs should also price. Italian drug container supplier Stevanato Group (STVN) plans to raise $900...read more